A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(11 sites)

Australia

The Children's Hospital at Westmead, Sydney, New South Wales

Queensland Children's Hospital, Brisbane, Queensland

Perth Children's Hospital, Perth, Washington

Austria

St. Anna Children's Hospital, Vienna

Belgium

UZ Leuven, Leuven

Netherlands

Princess Máxima Centre for Pediatric Oncology, Utrecht

New Zealand

Starship Children's Hospital, Auckland

Sweden

Sahlgrenska University Hospital, Gothenburg

United Kingdom

Birmingham Children's Hospital, Birmingham

Bristol Royal Hospital for Children, Bristol

Royal Manchester Children's Hospital, Manchester